Work

Alternative Splicing of MDM4 in Human Melanomas

Year: 2020
Type: article
Abstract: Alternative Splicing of MDM4 in Human MelanomasMelanoma is a potentially lethal type of skin cancer and regarded to be the third most common type of skin cancer.Although melanoma is not as common as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), it is more likely to metastasize than BCC and SCC.Interestingly, the incidence of melanoma continues to go up (expected 2% in 2020), but the deaths continue to decrease (-5.3% in 2020) due to improvements in detection and treatment.The treatment of melanoma depends on several aspects but most importantly the tumor's stage and the location.In the early stages, melanoma can be removed via surgical operation, but in the late stages, melanoma usually treated with radiation or targeted therapy.Many factors predict the development of melanoma like skin pigmentation, age, sun exposure (UV light), and genetic mutations.The p53 protein initiates apoptosis and cell cycle arrest in response to stresses v Table of Contents Page I. INTRODUCTION……………………………………………….……………..……….…. 1 A. Human Melanoma…………………………………………………...…………………….. 1 B. The Biology of Melanoma…………………………………………...…………………….2 C. Current Treatment of Cutaneous Melanoma……………………...……………………….. 4 D. Role of p53 in melanoma…………………………………………...……………………... 6 E. The p53 Interaction with MDM2/MDM4 in Melanoma……………...……………...…….7 F. MDM4 as a Therapeutic Target in Melanoma………………………………………..…… 11
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W3134902257
FWCI:
Cites: 113
Cited by:
Related to: 10